Respiratory disease is a huge global issue, with asthma and chronic obstructive pulmonary disease...

6 minute read
This year's Next Generation Nicotine Delivery USA Conference brought many of the same challenges as last year back under discussion, providing insight into the ongoing impasse within the US market. However, elsewhere in the world, opportunities for...
Filter
Filter
Respiratory disease is a huge global issue, with asthma and chronic obstructive pulmonary disease...
2 minute read
Our CEO Chris Allen has written about the need to act now on vape compliance following recent...
Broughton CEO, Chris Allen, looks at the emerging field of psychedelic pharmaceutical drug...
Broughton’s Chief Executive Officer, Chris Allen speaks to leading industry publication Cannabis...
Broughton's Chief Executive Officer, Chris Allen summarizes the highlights from Global Forum on...
Broughton's Chief Scientific Officer, Chris Allen shares his opinion with Financial Times about...
2 minute read
Broughton Chief Scientific Officer, Chris Allen shares his thoughts ahead of this year's Global...
3 minute read
Broughton Chief Scientific Officer, Chris Allen, discusses the sensitivity of analytical methods...
6 minute read
As the September 9th, 2020 PMTA deadline rapidly approaches, our Chief Scientific Officer, Chris...
Ensure your business stays ahead of the competition by keeping up to date on the latest regulatory changes. Sign-up for our bi-monthly regulatory digest to have the latest information and insights served direct to your inbox.